$1.46-2.67%
2026-10-06 close · prelimAllogene Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$273M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Allogene Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$273M.